ADIAL PHARMACEUTICALS, INC. reports leadership or board changes

ADIAL PHARMACEUTICALS, INC. filed an 8-K covering director or executive-officer changes, charter, bylaw or fiscal-year changes, a shareholder vote, and a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.